[1] Gu X, Zheng Q, Chu Q, et al. HAND2-AS1: A functional cancer-related long non-coding RNA [J]. Biomed Pharmacother, 2021, 137:111317. DOI: 10.1016/j.biopha.2021.111317.
[2] Razavi ZS, Tajiknia V, Majidi S, et al. Gynecologic cancers and non-coding RNAs: epigenetic regulators with emerging roles [J]. Crit Rev Oncol Hematol, 2021, 157: 103192. DOI: 10.1016/j.critrevonc.2020.103192.
[3] Kolenda T, Guglas K, Kopczyńska M, et al. Good or not good: role of miR-18a in cancer biology [J]. Rep Pract Oncol Radiother, 2020, 25(5): 808-819. DOI: 10.1016/j.rpor.2020.07.006.
[4] Li YH, Hu YQ, Wang SC, et al. LncRNA SNHG5: a new budding star in human cancers [J]. Gene, 2020, 749:144724. DOI: 10.1016/j.gene.2020.144724.
[5] Herrington CS, Poulsom R, Coates PJ. Recent advances in pathology: the 2020 annual review issue of The Journal of Pathology [J]. J Pathol, 2020, 250(5): 475-479. DOI: 10.1002/path.5425.
[6] 中国抗癌协会妇科肿瘤专业委员会. 子宫内膜癌诊断与治疗指南 [J].4版.中国实用妇科与产科杂志, 2018, 34(8):52-58.
[7] Song C, Zhang J, Zhao Z, et al. DLEU1: a functional long noncoding RNA in tumorigenesis [J]. Curr Pharm Des, 2020, 26(15):1742-1748. DOI: 10.2174/1381612826666200122145305.
[8] Wang R, Zou L. Downregulation of LncRNA-MEG3 promotes HTR8/SVneo cells apoptosis and attenuates its migration by repressing Notch1 signal in preeclampsia [J]. Reproduction, 2020, 160(1): 21-29. DOI: 10.1530/REP-19-0614.
[9] Liu B, Gao W, Sun W, et al. Promoting roles of long non-coding RNA FAM83H-AS1 in bladder cancer growth, metastasis, and angiogenesis through the c-Myc-mediated ULK3 upregulation [J]. Cell Cycle, 2020, 19(24): 3546-3562. DOI: 10.1080/15384101.2020.1850971.
[10] Ríos-Romero M, Cedro-Tanda A, Peña-Luna M, et al. FAM83H-AS1 is a potential modulator of cancer driver genes across different tumors and a prognostic marker for ER/PR + BRCA patients [J]. Sci Rep, 2020, 10(1): 14145. DOI: 10.1038/s41598-020-71062-2.
[11] El-Ashmawy NE, Hussien FZ, El-Feky OA, et al. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer [J]. Life Sci, 2020, 259: 118193. DOI: 10.1016/j.lfs.2020.118193.
[12] Feng B, Wang G, Liang X, et al. LncRNA FAM83H-AS1 promotes oesophageal squamous cell carcinoma progression via miR-10a-5p/Girdin axis [J]. J Cell Mol Med, 2020, 24(16):8962-8976. DOI: 10.1111/jcmm.15530.
[13] Wu Z, Tang H, Xiong Q, et al. Prognostic role of microRNA-205 in human gynecological cancer: a meta-analysis of fourteen studies [J]. DNA Cell Biol, 2020, 39(5):875-889. DOI: 10.1089/dna.2019.5316.
[14] Liu HE, Shi HH, Luo XJ. Upregulated long noncoding RNA UCA1 enhances warburg effect via miR-203/HK2 axis in esophagal cancer [J]. J Oncol, 2020:8847687. DOI: 10.1155/2020/8847687.
[15] Meng Y, Hu X, Li S, et al. miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1 [J]. BMC Cancer, 2020, 20(1): 1028. DOI: 10.1186/s12885-020-07472-2.
[16] Wang T, Wang J, Ren W, et al. CircRNA-0008717 promotes cell proliferation, migration, and invasion by regulating miR-203/Slug in esophageal cancer cells [J]. Ann Transl Med, 2020, 8(16): 999. DOI: 10.21037/atm-20-5205.
[17] Liu HP, Zhang Y, Liu ZT, et al. MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3 [J]. Eur Rev Med Pharmacol Sci, 2020, 24(15): 7914. DOI: 10.26355/eurrev_202008_22448.
[18] Northey JJ, Barrett AS, Acerbi I, et al. Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217 [J]. J Clin Invest, 2020, 130(11): 5721-5737. DOI: 10.1172/JCI129249.
[19] Sun X, Zheng X, Zhang X, et al. Exosomal microRNA-23b-3p from bone marrow mesenchymal stem cells maintains T helper/Treg balance by downregulating the PI3k/Akt/NF-κB signaling pathway in intracranial aneurysm [J]. Brain Res Bull, 2020, 165:305-315. DOI: 10.1016/j.brainresbull.2020.09.003.
[20] Wang B, Li R, Cai Y, et al. Alteration of DNA methylation induced by PM2.5 in human bronchial epithelial cells [J]. Toxicol Res (Camb), 2020, 9(4): 552-560. DOI: 10.1093/toxres/tfaa061.
|